近藤 征史

Medicine & Life Sciences

1. Lung Neoplasms 100%
2. Non-Small Cell Lung Carcinoma 91%
3. Lung 45%
4. Japan 33%
5. Cell Line 31%
6. Genes 29%
7. Smooth Muscle Myocytes 27%
8. Neoplasms 27%
9. Tumor Suppressor Genes 26%
10. Alleles 25%
11. Malignant Mesothelioma 24%
12. Smooth Muscle 24%
13. Anions 23%
14. Carboplatin 22%
15. Coronavirus 21%
16. Epithelial Cells 20%
17. Asthma 20%
18. Adenosine Triphosphate 20%
19. Mutation 20%
20. Loss of Heterozygosity 19%
21. rho-Associated Kinases 18%
22. Small Cell Lung Carcinoma 18%
23. Docetaxel 16%
24. Growth 16%
25. Idiopathic Pulmonary Fibrosis 16%
26. Pemetrexed 15%
27. Genomic Imprinting 15%
28. Drug Therapy 15%
29. Epithelium 14%
30. favipiravir 14%
31. Colforsin 14%
32. 130-nm albumin-bound paclitaxel 14%
33. Induced Pluripotent Stem Cells 14%
34. Survival 13%
35. Allelic Imbalance 13%
36. Apoptosis 13%
37. Therapeutics 13%
38. Safety 13%
39. Albumin-Bound Paclitaxel 12%
40. Somatomedins 12%
41. sphingosine 1-phosphate 11%
42. Menthol 11%
43. Gefitinib 11%
44. Prostaglandins 11%
45. Endothelial Cells 11%
46. Epithelial Cell Adhesion Molecule 11%
47. Anaplastic Lymphoma Kinase 10%
48. Observational Studies 10%
49. Catenins 10%
50. Cancer Pain 10%